ARWR

Arrowhead Pharmaceuticals
ARWR

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.64B
EV
$1.97B
Shares Outstanding
126.10M
Beta
1.00

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$45.64
P/E 2025E
-
P/Revenue 2025E
5.11x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Arrowhead Pharmaceuticals, Inc.

gainify
ARWR

Arrowhead Pharmaceuticals, Inc.

ARWR

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company’s products in pipeline includes Plozasiran, which is in Phase 2b and one Phase 3 clinical trial to treat hypertriglyceridemia, mixed dyslipid...

Sector

Healthcare

Industry

Biotechnology

CEO

Anzalone, Christopher

Employees

609

IPO Date

1993-12-16

Headquarters

177 East Colorado Boulevard, Suite 700, Pasadena, California, 91105, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved